Cargando…

The Metabolic Phenotype of Prostate Cancer

Prostate cancer is the most common non-cutaneous cancer in men in the United States. Cancer metabolism has emerged as a contemporary topic of great interest for improved mechanistic understanding of tumorigenesis. Prostate cancer is a disease model of great interest from a metabolic perspective. Pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eidelman, Eric, Twum-Ampofo, Jeffrey, Ansari, Jamal, Siddiqui, Mohummad Minhaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474672/ https://www.ncbi.nlm.nih.gov/pubmed/28674679 http://dx.doi.org/10.3389/fonc.2017.00131

Ejemplares similares

Hyperpolarized (13)C magnetic resonance imaging, using metabolic imaging to improve the detection and management of prostate, bladder, and kidney urologic malignancies
por: Vishwanath, Vijay, et al.
Publicado: (2018)

Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
por: Eidelman, Eric, et al.
Publicado: (2018)

Determining the component-based operative time learning curve for robotic-assisted radical prostatectomy
por: Ambinder, David, et al.
Publicado: (2022)

Learning curve for magnetic resonance imaging/ultrasound fusion prostate biopsy in detecting prostate cancer using cumulative sum analysis
por: Xu, Linhan, et al.
Publicado: (2023)

Structural equation modelling of COVID-19 knowledge and attitude as determinants of preventive practices among university students in Ghana
por: Ampofo, Richard Twum, et al.
Publicado: (2022)

Metabolic Imaging in Prostate Cancer: Where We Are
por: Testa, Claudia, et al.
Publicado: (2016)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
por: Jiménez, Natalia, et al.
Publicado: (2020)

Radiogenomics influence on the future of prostate cancer risk stratification
por: Banerjee, Vinayak, et al.
Publicado: (2022)

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
por: Fidelito, Gio, et al.
Publicado: (2022)

Identification of Metabolism-Related Gene-Based Subgroup in Prostate Cancer
por: Yu, Guopeng, et al.
Publicado: (2022)

Unbiased Phenotype-Based Screen Identifies Therapeutic Agents Selective for Metastatic Prostate Cancer
por: Chung, Ivy, et al.
Publicado: (2021)

Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2021)

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity
por: Jolly, Mohit Kumar, et al.
Publicado: (2018)

Digitoxin Inhibits Epithelial-to-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer
por: Pollard, Bette S., et al.
Publicado: (2019)

Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies
por: Vela, Driton
Publicado: (2018)

Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers
por: Kamada, Shuhei, et al.
Publicado: (2020)

The Interplay Between Prostate Cancer Genomics, Metabolism, and the Epigenome: Perspectives and Future Prospects
por: Singh, Reema, et al.
Publicado: (2021)

Development of Central Nervous System Vasculitis in a Patient with Waldenstrom Macroglobulinemia: A Rare Presentation with Poor Prognosis
por: Khan, Tahir Muhammad Abdullah, et al.
Publicado: (2019)

Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
por: Zhang, Yanlong, et al.
Publicado: (2020)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
por: Ashrafi, Akbar N., et al.
Publicado: (2020)

Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)

Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
por: Uo, Takuma, et al.
Publicado: (2020)

Metabolic Syndrome Is Not Associated With Prostate Cancer Recurrence: A Retrospective Analysis of a Chinese Cohort
por: Xu, Xin, et al.
Publicado: (2020)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
por: Andreas, Darian, et al.
Publicado: (2016)

Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomy
por: Sarkar, Arjun, et al.
Publicado: (2021)

LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
por: Zhao, Zhifeng, et al.
Publicado: (2020)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

Value of (11)C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
por: Zhou, Shuoming, et al.
Publicado: (2021)

Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation
Publicado: (2021)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
por: Karnes, R. Jeffrey, et al.
Publicado: (2018)

Impact of Sirtuin Enzymes on the Altered Metabolic Phenotype of Malignantly Transformed Cells
por: Gaál, Zsuzsanna, et al.
Publicado: (2020)

Novel Prognostic Signatures of Hepatocellular Carcinoma Based on Metabolic Pathway Phenotypes
por: Ye, Tingbo, et al.
Publicado: (2022)

Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
por: Frank, Sander B., et al.
Publicado: (2013)

Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
por: Che, Bangwei, et al.
Publicado: (2021)

Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer
por: Zhou, Yongheng, et al.
Publicado: (2022)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

Carbon Ion Radiotherapy Induce Metabolic Inhibition After Functional Imaging-Guided Simultaneous Integrated Boost for Prostate Cancer
por: Pei, Yulei, et al.
Publicado: (2022)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6f461pqa6cjd3lnp053d8imv9